Endo Pharmaceuticals Solutions Incorporated - Lexington, Massachusetts 02421

Endo Pharmaceuticals Solutions Incorporated is categorized under in Lexington, MA .

Business Name: Endo Pharmaceuticals Solutions Incorporated
Contact Person: Glenn Cooper
Address: 33 Hayden Avenue, Lexington, Massachusetts 02421
Phone Number: (704) 376-0975
Website Address: endo.com
Annual Revenue (USD): Unknown
Founding Year: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category:
SIC Code: 2834
NAICS Code: 325412
Share This Business:
Related Businesses: Nitromed Inc - Lexington, MA 02421
Biousian Biosystems Inc (Bbi) - Lexington, MA 02421
Ledgemont Royalty Sub LLC - Lexington, MA 02421
Concert Pharmaceuticals Inc - Lexington, MA 02421
Novatarg Pharmaceuticals - Lexington, MA 02421
Synerz Pharmaceuticals - Lexington, MA 02421
Pulmatrix Inc - Lexington, MA 02421
Interneuron Pharmaceutical - Lexington, MA 02421
Synta Pharmaceuticals Corp - Lexington, MA 02421
Eyegate Pharmaceuticals - Lexington, MA 02421
Adolor Corporation - Lexington, MA 02421
Shafa Pharmaceuticals Inc - Lexington, MA 02421
Cubist Pharmaceuticals Inc - Lexington, MA 02421
Endo Pharmaceuticals Inc - Lexington, MA 02421

The company Endo Pharmaceuticals Solutions Incorporated provides BOTH services in the form of from its single location in Massachusetts. 1 to 4 employees work for Endo Pharmaceuticals Solutions Incorporated, and the business now earns Unknown per annum.

Endo Pharmaceuticals Solutions Incorporated was launched in 2010 and is classified under SIC code and category 2834 , and NAICS number and grouping 325412 . To contact Endo Pharmaceuticals Solutions Incorporated, please call Glenn Cooper with the phone number (704) 376-0975 or visit its single location at 33 Hayden Avenue in Lexington, Massachusetts 02421.

The location of the single location can also be found using the coordinates 42.423068,-71.233917. Read more details about this business on the webpage endo.com or follow the company’s social media accounts, on Twitter and on Facebook.